Lipoprotein (a) and long-term outcome in patients with peripheral artery disease undergoing revascularization.

MLA

Zierfuss, Bernhard, et al. “Lipoprotein (a) and Long-Term Outcome in Patients with Peripheral Artery Disease Undergoing Revascularization.” Atherosclerosis, vol. 363, Dec. 2022, pp. 94–101. EBSCOhost, https://doi.org/10.1016/j.atherosclerosis.2022.10.002.

APA

Zierfuss, B., Höbaus, C., Feldscher, A., Hannes, A., Mrak, D., Koppensteiner, R., Stangl, H., & Schernthaner, G.-H. (2022). Lipoprotein (a) and long-term outcome in patients with peripheral artery disease undergoing revascularization. Atherosclerosis, 363, 94–101. https://doi.org/10.1016/j.atherosclerosis.2022.10.002

Chicago

Zierfuss, Bernhard, Clemens Höbaus, Anna Feldscher, Antonia Hannes, Daniel Mrak, Renate Koppensteiner, Herbert Stangl, and Gerit-Holger Schernthaner. 2022. “Lipoprotein (a) and Long-Term Outcome in Patients with Peripheral Artery Disease Undergoing Revascularization.” Atherosclerosis 363 (December): 94–101. doi:10.1016/j.atherosclerosis.2022.10.002.